Cargando…
Microfluidic characterisation reveals broad range of SARS-CoV-2 antibody affinity in human plasma
The clinical outcome of SARS-CoV-2 infections, which can range from asymptomatic to lethal, is crucially shaped by the concentration of antiviral antibodies and by their affinity to their targets. However, the affinity of polyclonal antibody responses in plasma is difficult to measure. Here we used...
Autores principales: | Schneider, Matthias M, Emmenegger, Marc, Xu, Catherine K, Condado Morales, Itzel, Meisl, Georg, Turelli, Priscilla, Zografou, Chryssa, Zimmermann, Manuela R, Frey, Beat M, Fiedler, Sebastian, Denninger, Viola, Jacquat, Raphaël PB, Madrigal, Lidia, Ilsley, Alison, Kosmoliaptsis, Vasilis, Fiegler, Heike, Trono, Didier, Knowles, Tuomas PJ, Aguzzi, Adriano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Life Science Alliance LLC
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645332/ https://www.ncbi.nlm.nih.gov/pubmed/34848436 http://dx.doi.org/10.26508/lsa.202101270 |
Ejemplares similares
-
Serological fingerprints link antiviral activity of therapeutic antibodies to affinity and concentration
por: Fiedler, Sebastian, et al.
Publicado: (2022) -
Both COVID-19 infection and vaccination induce high-affinity cross-clade responses to SARS-CoV-2 variants
por: Emmenegger, Marc, et al.
Publicado: (2022) -
Protocol to determine antibody affinity and concentration in complex solutions using microfluidic antibody affinity profiling
por: Emmenegger, Marc, et al.
Publicado: (2023) -
Continuous population-level monitoring of SARS-CoV-2 seroprevalence in a large European metropolitan region
por: Emmenegger, Marc, et al.
Publicado: (2023) -
Mechanistic Models of Protein Aggregation Across Length-Scales and Time-Scales: From the Test Tube to Neurodegenerative Disease
por: Meisl, Georg, et al.
Publicado: (2022)